233412
Ethyl (hydroxyimino)cyanoacetate
97%, for peptide synthesis
Synonym(s):
Ethyl cyano(hydroxyimino)acetate, Ethyl cyanoglyoxalate-2-oxime, Ethyl isonitrosocyanoacetate
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
NCC(=NOH)CO2C2H5
CAS Number:
Molecular Weight:
142.11
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
223-351-3
MDL number:
Beilstein/REAXYS Number:
774783
Product Name
Ethyl (hydroxyimino)cyanoacetate, 97%
InChI key
LCFXLZAXGXOXAP-QPJJXVBHSA-N
InChI
1S/C5H6N2O3/c1-2-10-5(8)4(3-6)7-9/h9H,2H2,1H3/b7-4+
SMILES string
CCOC(=O)C(=N\O)\C#N
assay
97%
form
solid
Quality Level
mp
130-132 °C (lit.)
application(s)
peptide synthesis
functional group
amine, ester, nitrile, oxime
General description
Ethyl (hydroxyimino)cyanoacetate is a potential replacement for zobenzotriazole and benzotriazole derivatives used in peptide synthesis.
Ethyl (hydroxyimino)cyanoacetate is also called as Oxyma. It is a highly efficient greener alternative for the amide and peptide synthesis.
Ethyl (hydroxyimino)cyanoacetate is also called as Oxyma. It is a highly efficient greener alternative for the amide and peptide synthesis.
Application
Ethyl (hydroxyimino)cyanoacetate has been used as an additive for the carbodiimide-mediated amide bond formation during established peptide synthesis method.For peptide synthesis grade material, please see product 851086.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Minimizing HCN in DIC/Oxyma-mediated amide bond-forming reactions
Erny, Marion and Lundqvist, et al.
Organic Process Research & Development, 24, 1341-1349 (2020)
Doaa M Anwar et al.
Bioconjugate chemistry, 29(9), 3026-3041 (2018-08-16)
In this study, promising approaches of dual-targeted micelles and drug-polymer conjugation were combined to enable injection of poorly soluble anticancer drugs together with site-specific drug release. Ursodeoxycholic acid (UDCA) as a hepatoprotective agent was grafted to maltodextrin (MD) via carbodiimide
Valeria Tarallo et al.
International journal of molecular sciences, 21(2) (2020-01-16)
Age-related macular degeneration (AMD) is the primary cause of blindness in advanced countries. Repeated intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents has represented an important advancement for the therapy of wet AMD with significative results in terms of
Alvin W Hung et al.
Proceedings of the National Academy of Sciences of the United States of America, 108(17), 6799-6804 (2011-04-13)
Fragment-based drug discovery (FBDD) has proven to be an effective means of producing high-quality chemical ligands as starting points for drug-discovery pursuits. The increasing number of clinical candidate drugs developed using FBDD approaches is a testament of the efficacy of
Virginia Brancato et al.
Acta biomaterialia, 57, 47-58 (2017-05-10)
Therapeutic approaches based on nanomedicine have garnered great attention in cancer research. In vitro biological models that better mimic in vivo conditions are crucial tools to more accurately predict their therapeutic efficacy in vivo. In this work, a new 3D
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service